Examples of drugs that can raise the risk of serotonin syndrome if taken with Vyvanse include: selective serotonin reuptake inhibitor (SSRI) antidepressants, such as: paroxetine (Paxil, Pexeva) sertraline (Zoloft) escitalopram (Lexapro) fluoxetine (Prozac) serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressants, such as: lithium (Lithobid), a drug for bipolar disorder and depression buspirone, a drug for anxiety triptan medications for migraine, such as: almotriptan (Axert) eletriptan (Relpax) frovatriptan (Frova) naratriptan (Amerge) rizatriptan (Maxalt) sumatriptan (Imitrex) zolmitriptan (Zomig) certain pain medications, such as: other amphetamine drugs, such as: amphetamine (Evekeo, Adzenys, Dynavel) amphetamine/dextroamphetamine (Adderall, Mydayis) dextroamphetamine (Dexedrine) methamphetamine (Desoxyn) monoamine oxidase inhibitors (MAOIs), such as: phenelzine (Nardil) isocarboxazid (Marplan) If you take any of these drugs, talk with your doctor before taking Vyvanse

Peer review Peer review information Nature Communications thanks Xiaoshun He and the other anonymous reviewer(s) for their contribution to the peer review of this work
For PA-NOT-MET denials, file a level-1 internal appeal with Express Scripts within 180 days
Drivers of Recent Interest in GLP-1RA Though GLP-1RAs have been available for close to 20 years, there has been a surge in recent interest amongst the business community
So, lets explore what it really takes the challenges, logistics, fulfillment, insurance, and telehealth integration to build a successful, compliant, and future-ready GLP-1 program inside your pharmacy